Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Vaccine ; 19(17-19): 2749-55, 2001 Mar 21.
Artículo en Inglés | MEDLINE | ID: mdl-11257419

RESUMEN

The efficacy of edible vaccines produced in potato tubers was examined in mice. Transgenic plants were developed by Agrobacterium tumefaciens-mediated transformation. The antigen selected was the non-toxic B subunit of the Escherichia coli enterotoxin (recLT-B). A synthetic gene coding for recLT-B was made and optimised for expression in potato tubers and accumulation in the endoplasmic reticulum. Introduction of this gene under control of the tuber-specific patatin promoter in potato plants resulted in the production of functional, i.e. Gm1-binding, recLT-B pentamers in tubers. Selected tubers containing about 13 microg of recLT-B per gram fresh weight were used for immunisation. Subcutaneous immunisation with an extract of recLT-B tubers yielded high antibody titres in serum that were similar to those obtained with bacterial recLT-B. The efficacy of oral administration of recLT-B tubers was determined by measuring mucosal and systemic immune responses in naive and primed mice. Animals were primed by subcutaneous injection of an extract of recLT-B tuber plus adjuvant. Naive and primed mice were fed 5 g of tubers ( approximately 65 microg of recLT-B) or were intubated intragastrically with 0.4 ml of tuber extract ( approximately 2 microg of recLT-B). In naive mice, feeding recLT-B tubers or intubation of tuber extract did not induce detectable anti-LT antibody titres. In primed animals, however, oral immunisation resulted in significant anti-LT IgA antibody responses in serum and faeces. Intragastric intubation of tuber extract revealed higher responses than feeding of tubers. These results indicate clearly that functional recLT-B can be produced in potato tubers, that this recombinant protein is immunogenic and that oral administration thereof elicits both systemic and local IgA responses in parentally primed, but not naive, animals.


Asunto(s)
Toxinas Bacterianas/administración & dosificación , Toxinas Bacterianas/genética , Enterotoxinas/administración & dosificación , Enterotoxinas/genética , Proteínas de Escherichia coli , Solanum tuberosum/genética , Solanum tuberosum/inmunología , Vacunas Comestibles/administración & dosificación , Vacunas Comestibles/genética , Administración Oral , Animales , Anticuerpos Antibacterianos/sangre , Toxinas Bacterianas/inmunología , Enterotoxinas/inmunología , Femenino , Inmunización Secundaria , Inmunoglobulina A/sangre , Ratones , Plantas Modificadas Genéticamente/genética , Plantas Modificadas Genéticamente/inmunología , Transformación Genética
2.
Vaccine ; 19(1): 132-41, 2000 Aug 15.
Artículo en Inglés | MEDLINE | ID: mdl-10924795

RESUMEN

The antibody and cell mediated immune responses induced by BHV-1 were analysed in cattle after vaccination and challenge exposure to the virulent strain LA of BHV-1. Animals were vaccinated intramuscularly (IM) with inactivated virus vaccines against BHV-1 containing either a water in mineral oil adjuvant (W/O), a water in mineral oil adjuvant plus Avridine (W/O+Avridine) or sulfolipo-cyclodextrin in squalane in-water emulsion (SL-CD/S/W). No significant differences were registered in the antibody response induced by the three evaluated vaccines. However, the BHV-1 specific cell-mediated immunite response was stronger and appeared earlier when SL-CD/S/W was included in the formulation. The efficacy of the vaccines was also evaluated after intranasal challenge of the calves with a virulent BHV-1 LA strain. Animals vaccinated with SL-CD/S/W had reduced virus excretion and clinical symptoms compared with the mock-vaccinated animals. Comparison of levels of BHV-1 specific IgG2 and IgG1 with virus shedding revealed that, regardless of the adjuvant administered, animals showing BHV-1 specific IgG2/IgG1 ratios higher than 1 were those with a significant lower number of individuals shedding virus. Additionally, animals vaccinated with SL-CD/S/W presented no post-vaccinal reactions. These factors, combined with the higher efficacy and the ease of manipulation of the biodegradable oil, makes the vaccine formulated with this new adjuvant an important contribution for the veterinary vaccines industry.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Ciclodextrinas/administración & dosificación , Herpesvirus Bovino 1/inmunología , Rinotraqueítis Infecciosa Bovina/prevención & control , Escualeno/análogos & derivados , Vacunas de Productos Inactivados/administración & dosificación , Vacunas Virales/administración & dosificación , Animales , Anticuerpos Antivirales/análisis , Formación de Anticuerpos/efectos de los fármacos , Bovinos , Ciclodextrinas/inmunología , Emulsiones/administración & dosificación , Inmunidad Celular/efectos de los fármacos , Inmunoglobulina G/análisis , Activación de Linfocitos/inmunología , Aceite Mineral/administración & dosificación , Pruebas de Neutralización , Escualeno/administración & dosificación , Escualeno/inmunología , Vacunas de Productos Inactivados/inmunología , Vacunas Virales/inmunología , Esparcimiento de Virus/inmunología , Agua/administración & dosificación
3.
Vaccine ; 17(3): 219-28, 1999 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-9987157

RESUMEN

Previously, we described synergistic adjuvanticity of combinations of synthetic sulfolipo(SL)-derivatives of polysaccharide (SL-polysaccharides) and squalane-in-water emulsions (squalane/W). In this paper, effects of type of polysaccharide and nature of oil on adjuvanticity, reactogenicity and stability are described. SL-derivatives of the following polysaccharides were synthesised: synthetic polysucroses with weight-average molecular weight (MW) of 400,000 (Ficoll400), 70,000 (Ficoll70) and 39,000 Da (Ficoll39), polyfructose of 5,000 Da (inulin), linear polyglucose of 1,200 Da (maltodextrin) and cyclic polyglucose of 1,135 Da (beta-cyclodextrin). The number of sulphate groups per monosaccharide of the different SL-polysaccharides varied between 0.15 and 0.23 and the number of lipid groups per monosaccharide between 1.15 and 1.29. Adjuvant formulations were prepared by incorporating these SL-polysaccharides into oil-in-water emulsions of either squalane, hexadecane, soya oil or mineral oil. Adjuvanticity of the formulations obtained for humoral responses to inactivated pseudorabies virus (PRV) and inactivated influenza virus strains A/Swine (A/Swine) and MRC-11 (MRC-11) in pigs and MRC-11 and ovalbumin (OVA) in mice depended on the type of oil (squalane = mineral oil > hexadecane = soya oil) but not on the type of polysaccharide backbone of the SL-derivative. Reactogenicity assessed by local swelling in mice decreased with decreasing MW (SL-Ficoll400 = Ficoll70 = Ficoll39 > SL-inulin = SL-maltodextrin > SL-cyclodextrin) when combined with squalane and decreased with the type of oil in the following order: squalane > mineral oil > hexadecane > soya oil when combined with SL-Ficoll400. Stability of the SL-polysaccharide/squalane/W emulsions at elevated temperature increased with decreasing MW of the SL-polysaccharide (SL-Ficoll400 < SL-Ficoll70 = SL-Ficoll39 < SL-inulin = SL-maltodextrin = SL-cyclodextrin). SL-cyclodextrin/squalane/W remained stable for > 2.5 years at 4 degrees C, > 18 weeks at 37 degrees C and > 10 days at 60 degrees C. We concluded that reactogenicity and stability but not adjuvanticity of SL-polysaccharide/squalane/W formulations depended on the MW of SL-polysaccharide and that SL-cyclodextrin/squalane/W is a promising non-mineral oil adjuvant as it combines strong adjuvanticity (i.e. better than the mineral oil-based adjuvant presently applied) with low reactogenicity and good stability.


Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Ciclodextrinas/uso terapéutico , Herpesvirus Suido 1/inmunología , Vacunas contra la Influenza , Vacunas Virales , Adyuvantes Inmunológicos/efectos adversos , Animales , Ciclodextrinas/efectos adversos , Estabilidad de Medicamentos , Emulsiones , Ratones , Ratones Endogámicos , Polisacáridos/análisis , Polisacáridos/biosíntesis , Escualeno/análogos & derivados , Porcinos , Agua
4.
Vet Immunol Immunopathol ; 66(2): 159-71, 1998 Nov 24.
Artículo en Inglés | MEDLINE | ID: mdl-9860188

RESUMEN

Stimulatory effects of several types of adjuvants on secondary antibody response to inactivated Newcastle disease virus (iNDV) were examined in chickens. For this purpose, animals were primed with iNDV without adjuvant resulting in a low but significant antibody response, boosted with iNDV plus adjuvant 3 weeks later, and analysed for specific antibody titres in serum 3 weeks after the booster. Water-in-mineral oil emulsion (W/O) caused significant increase in antibody titres measured in an indirect enzyme-linked immunosorbent (ELISA), haemagglutination inhibition (HI), and virus neutralisation (VN) assay. The adjuvants tested included three oil-in-water emulsions (i.e. mineral oil-in-water, sulpholipo(SL)-Ficoll400/squalane-in-water and sulpholipo-cyclodextrin/squalane-in-water), three negatively-charged polymers with high molecular weight (i.e. polyacrylate, polystyrenesulphonate and sulpho(S)-Ficoll400) and two surface-active agents (i.e. dimethyldioctadecylammonium bromide (DDA) and Quil A). These adjuvants enhanced significantly the secondary immune response but none reached the titre obtained with W/O. Combinations of adjuvants with distinct physicochemical properties, i.e. polyacrylate and DDA revealed only slight, beneficial effects. We concluded that the various types of adjuvants tested can stimulate secondary immune responses in primed animals but that W/O is superior.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Anticuerpos Antivirales/biosíntesis , Pollos/inmunología , Inmunización Secundaria/veterinaria , Virus de la Enfermedad de Newcastle/inmunología , Vacunas Virales/inmunología , Animales , Anticuerpos Antivirales/sangre , Embrión de Pollo , Emulsiones , Ensayo de Inmunoadsorción Enzimática/veterinaria , Pruebas de Hemaglutinación/veterinaria , Inmunización Secundaria/métodos , Aceite Mineral/farmacología , Pruebas de Neutralización/veterinaria , Enfermedad de Newcastle/inmunología , Enfermedad de Newcastle/prevención & control , Polímeros/farmacología , Organismos Libres de Patógenos Específicos , Tensoactivos/farmacología , Vacunas de Productos Inactivados/inmunología
5.
Vaccine ; 16(16): 1575-81, 1998 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9711806

RESUMEN

Previously, we demonstrated that polyacrylic acid (PAA) augmented significantly the immune response to inactivated Newcastle disease virus (iNDV) in chickens, but that efficacy was insufficient to replace the water-in-mineral oil (W/O) adjuvant applied for boosting primed animals. Attempting to improve its adjuvanticity, PAA with weight-average molecular weight (Mw) of 450 kDa was grafted with alkyl-chains by esterifying the carboxylic groups with octanol and butanol. The butyl-PAA and octyl-PAA esters obtained varied in degree of esterification between 10% and 92%. Adjuvant activity of water-soluble esters for humoral responses to iNDV was examined in chickens primed previously with iNDV without adjuvant. The alkyl-PAA esters exhibited significantly higher responses than unmodified PAA and titres increased with increasing dose of adjuvant. At doses of 2 mg per animal, octyl- and butyl-PAA esters with a substitution rate of 16% (octyl16-PAA and butyl16-PAA, respectively) gave similar titres as W/O. In aged animals primed with live NDV at early age, butyl16-PAA and W/O elicited comparable antibody responses. Butyl16-PAA was also more effective than PAA in stimulating primary immune responses in mice which was accompanied by stronger local reaction determined by monitoring swelling at the site of injection. Reactogenicity of butyl16-PAA was less than of W/O. We concluded that alkyl-PAA esters are strong adjuvants for primary and secondary responses and that they are promising alternatives to the mineral oil-based adjuvants presently used in various veterinary vaccines.


Asunto(s)
Resinas Acrílicas/farmacología , Adyuvantes Inmunológicos/farmacología , Vacunas Virales/inmunología , Vacunas Virales/farmacología , Resinas Acrílicas/síntesis química , Adyuvantes Inmunológicos/síntesis química , Animales , Anticuerpos Antivirales/biosíntesis , Anticuerpos Antivirales/sangre , Formación de Anticuerpos/efectos de los fármacos , Pollos , Ensayo de Inmunoadsorción Enzimática , Ésteres/inmunología , Femenino , Ratones , Enfermedad de Newcastle/inmunología , Virus de la Enfermedad de Newcastle/inmunología
6.
Vaccine ; 12(7): 653-60, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-8085385

RESUMEN

Sulfolipopolysaccharides (SLPs) were synthesized by reaction of the synthetic polysucrose polymer Ficoll-400 with chlorosulfonic acid and lauroyl chloride in anhydrous medium. Hydrophobic derivatives were obtained by addition of a small number of sulfate and a large number of lipid groups. Gel-permeation high-performance liquid chromatography (g.p.-h.p.l.c.) exhibited a wide range in molecular weight of both Ficoll-400 and SLP polymers. The calculated weight-average molecular weight (Mw) of Ficoll-400 and SLP using polystyrene polymers as references was 187,000 and 380,000 respectively, exhibiting a twofold increase in molecular weight upon derivatization. Adjuvanticity of hydrophobic SLPs with 0.2 sulfate and 1.5 lipid groups per sucrose monomer, a squalane-in-water emulsion (S/W), SLP incorporated into S/W (SLP/S/W), and a mineral oil-based emulsion (O/W) was investigated in combination with different antigens in mice and guinea-pigs. Antibody responses in serum against ovalbumin (OVA), dinitrophenylated bovine serum albumin (DNP-BSA), inactivated influenza virus strain MRC-11 (MRC-11), a mixture of three influenza virus strains (iFlu3) and inactivated pseudorabies virus (iPRV) were measured by either haemagglutination (HA), haemagglutination inhibition (HI) or serum neutralization (SN). Vaccines were prepared by simply mixing one volume of antigen with one volume of adjuvant solution. Antibody titres after one or two injections with these antigens were enhanced significantly by SLP/S/W, SLP, S/W and O/W and in most studies, SLP/S/W was demonstrated to be more effective than either the two constituent components or the O/W adjuvant.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Adyuvantes Inmunológicos , Lipopolisacáridos/farmacología , Animales , Formación de Anticuerpos , Emulsiones , Femenino , Lipopolisacáridos/química , Ratones , Aceite Mineral , Peso Molecular , Orthomyxoviridae/inmunología , Ovalbúmina/inmunología , Tamaño de la Partícula , Vehículos Farmacéuticos , Escualeno/análogos & derivados , Azufre , Agua
7.
Vaccine ; 12(7): 661-5, 1994 May.
Artículo en Inglés | MEDLINE | ID: mdl-8085386

RESUMEN

The adjuvanticity of a sulfolipopolysaccharide (SLP) incorporated into a squalane-in-water emulsion (SLP/S/W) was compared with that of a mineral oil-in-water (O/W) adjuvant currently used in commercial porcine vaccines. Groups of pigs were immunized twice with vaccines comprising either inactivated influenza virus (iFlu3 containing strains A/Swine, MRC-11 and X-79), inactivated pseudorabies virus (iPRV), live pseudorabies virus (PRV) or inactivated porcine parvovirus (iPPV) as antigen and SLP/S/W or O/W as adjuvant. Antibody titres in serum 2 or 3 weeks after the second immunization were measured by haemagglutination inhibition (HI) or serum neutralization (SN) assays. Both adjuvants significantly augmented the antibody responses against the antigens tested. Mean factors of increase obtained by SLP/S/W and O/W were: 315 and 91, respectively, for A/Swine; 478 and 137 for MRC-11; 362 and 128 for X-79; 69 and 49 for iPRV; and 23 and 7 for live PRV. Increased humoral immunity against live PRV was affirmed by reduced levels and duration of virus excreted by pigs after challenge with virulent PRV. Immunization of pigs with iPPV plus adjuvant SLP/S/W gave 36-fold higher titres than with O/W. It was concluded that SLP/S/W is more effective than O/W in stimulating humoral immunity against the viral antigens examined and that the two constituents SLP and S/W interact synergistically. Advantages of SLP/S/W over O/W include stronger adjuvanticity, better biocompatibility and lower doses of active substances.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Lipopolisacáridos/farmacología , Animales , Formación de Anticuerpos/efectos de los fármacos , Emulsiones , Femenino , Ratones , Aceite Mineral , Peso Molecular , Orthomyxoviridae/inmunología , Ovalbúmina/inmunología , Tamaño de la Partícula , Vehículos Farmacéuticos , Escualeno/análogos & derivados , Azufre , Vacunas de Productos Inactivados/inmunología , Agua
8.
Immunology ; 60(1): 141-6, 1987 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2880796

RESUMEN

Referring to the strong immunostimulating activity of combinations of lipophilic agents and dextran sulphate, conjugates with chemical determinants of both types of adjuvants were synthesized and then examined for immunostimulatory capabilities in mice. Saturated fatty acids with varying chain lengths and sulphate groups were coupled covalently at defined ratios to the polysaccharide Ficoll (MW 400,000). Chemical analysis of 60 of the sulpholipopolysaccharides synthesized revealed that the number of sulphate groups per monosaccharide unit varied from 0 to 1.6, and the number of lipid groups from 0 to 0.8. Adjuvanticity of these conjugates for the humoral immune response was determined using sheep red blood cells (SRBC) and dinitrophenyl-haptenated bovine serum albumin (DNP-BSA) as antigens. Five days after intraperitoneal injection of adjuvant and antigen, the numbers of direct anti-SRBC plaque-forming cells (PFC) in the spleen were determined. Anti-DNP antibody titres were measured from 1 to 4 weeks after immunization. PFC responses to 2 X 10(6) SRBC were augmented up to a 100-fold by conjugates of Ficoll and sulphate (sulphopolysaccharides: SPs) or lipid groups (lipopolysaccharides: LPs). Introduction of low or moderate numbers of lipid groups in SPs reduced adjuvanticity. Adjuvant activity of sulpholipopolysaccharides (SLPs) with varying sulphate and high lipid content depended on the sulphate contents and the chain length of the lipids. Sulphate reduced adjuvanticity of the SLPs, and the number of sulphate groups required for complete annihilation increased with the chain length of the lipid. LPs and SLPs, including conjugates that did not enhance anti-SRBC PFC responses, augmented serum antibody responses to DNP-BSA while SPs were hardly effective.


Asunto(s)
Adyuvantes Inmunológicos/farmacología , Lipopolisacáridos/inmunología , Polisacáridos/inmunología , Animales , Formación de Anticuerpos , Dinitrofenoles/inmunología , Relación Dosis-Respuesta Inmunológica , Femenino , Técnica de Placa Hemolítica , Lípidos/inmunología , Lipopolisacáridos/biosíntesis , Ratones , Ratones Endogámicos BALB C , Palmitatos/inmunología , Polisacáridos/biosíntesis , Albúmina Sérica Bovina/inmunología , Relación Estructura-Actividad , Sulfatos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA